Latest News - LabCorp
Top Corporates Hub
LabCorp
Did Labcorp’s (LH) AI Push with Epic and MyLabcorp Just Recast Its Digital Health Ambitions?
22.05.2026 08:24
Earlier in May 2026, Labcorp announced an expanded collaboration with Epic, making its full test menu available through Aura, Epic's unified platform that simplifies lab ordering, interfaces and test access for hospitals and health systems using Epic nationwide. A few days later, Labcorp launched MyLabcorp™, an AI-powered mobile app that uses OpenAI models to provide personalized lab result explanations and health education, highlighting the company's push to integrate advanced technology...
Labcorp Launches MyLabcorp™, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results and Track Health Trends Over Time
20.05.2026 11:00
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of MyLabcorp™, an AI-powered mobile app that brings together lab results, AI-enabled features and clinical guideline-based content in a secure, personalized mobile experience. The app is designed to give users additional context about their health and support more informed conversations with healthcare providers.
TNDM Stock Down Following Q1 Earnings & Revenue Beat, Gross Margin Up
14.05.2026 12:37
Tandem Diabetes beats Q1 revenue and earnings estimates as gross margin expands, but shares decline 23.6% after the results announcement.
Labcorp expands Epic pact to make full test menu available on Aura
14.05.2026 10:00
The Labcorp agreement continues the expansion of Aura, which gives healthcare providers access to tests from companies including Quest Diagnostics.
Hims & Hers Stock Plunges Post Q1 Earnings Miss, Gross Margin Down
12.05.2026 15:45
HIMS reports an adjusted loss and a revenue miss in first-quarter 2026 as gross margin decreases, but it lifts its full-year revenue outlook.
Labcorp Holdings (LH) is Positioned to Benefit from Demographic Trends
12.05.2026 12:52
Jensen Investment Management, an asset management company based in the US, released its first-quarter 2025 investor letter for the “Jensen Quality Mid Cap Fund”. A copy of the letter is available to download here. The Jensen Quality Mid Cap Fund aims for long-term growth. The Fund returned -2.53% in Q1 2026, lagging the 0.60% return for […]
Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systems
12.05.2026 11:00
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with Epic, the nation's leading electronic health record (EHR) supporting hospitals and health systems. Through the collaboration, Labcorp's full test menu will be available through Aura, Epic's unified platform for ordering and receiving lab results. The integration will drive meaningful operational efficiencies, streamline lab ordering for clinicians and care teams
Drug Screening Market Research and Global Forecast Report 2026-2036: Increasing Demand in Various Sectors Such As Workplaces, Criminal Justice Systems, and Drug Treatment Centers
08.05.2026 13:14
The global drug screening market is set to surge from USD 8.29 billion in 2026 to approximately USD 25.3 billion by 2036, growing at a CAGR of 11.8%, according to a forecast report. Key growth drivers include increased workplace safety concerns and the expansion of substance abuse prevention programs. The report segments the market by product type (analyzers, rapid testing devices, consumables, services), sample type (urine, oral fluid, breath, hair), technology, end user, and application areas.
CVS Health Q1 Earnings & Revenues Top Estimates, Stock Up in Pre-Market
06.05.2026 14:45
CVS beats Q1 estimates as revenues hit $100.43B, margins expand, and 2026 guidance is raised. Shares jump 4.8% in pre-market.
Here's Why Labcorp (LH) Is a Great 'Buy the Bottom' Stock Now
06.05.2026 13:55
Labcorp (LH) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
1 of Wall Street’s Favorite Stock with Competitive Advantages and 2 We Turn Down
05.05.2026 05:00
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Labcorp Q1 Earnings Call Highlights
02.05.2026 01:05
Labcorp (NYSE:LH) reported first-quarter 2026 results management described as a “strong start” to the year, citing revenue growth, margin expansion, and progress across strategic priorities in diagnostics, biopharma laboratory services, specialty testing, consumer health, and technology initiatives.
Labcorp (LH) Q1 2026 Earnings Call Transcript
01.05.2026 01:33
With me today are Adam Schechter, our Chairman and Chief Executive Officer; and Julia Wang, our Executive Vice President and Chief Financial Officer. This morning, in the Events section of the Labcorp Investor Relations website at ir.labcorp.com, we posted both our press release and a supplemental financial presentation with additional information on our business and operations. Please see the Use of Adjusted Measures section in the supplemental presentation for more information regarding our use of non-GAAP financial measures.
Is This the Right Time to Hold IART Stock in Your Portfolio?
28.04.2026 12:24
Integra shows growth promise from strong CSS demand and global expansion, but debt load and macro pressures raise concerns for investors.
Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA®
22.04.2026 11:00
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of Agilent Technologies' PD-L1 IHC 22C3 pharmDx, the only companion diagnostic approved by the U.S. Food and Drug Administration (FDA) to identify patients with platinum-resistant ovarian cancer who may be eligible for Merck's KEYTRUDA®.iKEYTRUDA (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) are the first FDA-approved PD-1 inhib
Ultima Genomics releases groundbreaking TRACERx MRD data showing ppmSeq performance and unveils clinical progress of whole genome sequencing at inaugural global MRD Symposium at AACR 2026
17.04.2026 12:00
Ultima Genomics, a developer of an innovative, ultra-high throughput sequencing architecture today announced key milestones for its ppmSeq® technology with a growing body of evidence from data presented across six abstracts, including an oral session and a plenary session at the 2026 AACR Annual Meeting in San Diego, taking place April 17–22, 2026. Highlighting the program will be initial TRACERx MRD data showcasing the performance of ppmSeq relative to ultrasensitive bespoke panels. Data from c
Labcorp’s Rapid Fentanyl Test Clearance And What It Means For Valuation
16.04.2026 02:10
Labcorp Holdings (NYSE:LH) has received the first FDA clearance for a rapid fentanyl urine test for use in emergency and clinical settings. The test is designed to give healthcare teams quick, reliable information on fentanyl exposure so they can act faster in acute care situations. This clearance highlights Labcorp's role in addressing the ongoing opioid crisis through expanded diagnostic capabilities. For investors tracking Labcorp Holdings at a share price of $266.73, this FDA clearance...
Labcorp Introduces Ai-Powered Real-World Data Platform with Aws and Datavant
14.04.2026 13:08
Labcorp announced a new AI-powered real-world data platform, designed to help researchers and biopharmaceutical companies analyze Alzheimer's disease-related data faster. Developed with Amazon Web...
Labcorp Introduces AI-Powered Real-World Data Platform with AWS and Datavant to Accelerate Alzheimer's Research
14.04.2026 11:00
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced a new AI-powered real-world data platform, designed to help researchers and biopharmaceutical companies analyze Alzheimer's disease-related data faster. Developed with Amazon Web Services (AWS) and Datavant, the platform provides access to large, diverse datasets and advanced analytics—using deidentified, privacy-protected healthcare data—designed to accelerate scientific discovery, shorten d
Labcorp Launches AI-Powered, Real-World Data Platform Developed With AWS And Datavant That Aims To Analyze Alzheimer's Disease-Related Data Faster
14.04.2026 07:09
Developed with Amazon Web Services (AWS) and Datavant, the platform provides access to large, diverse datasets and advanced analytics—using deidentified, privacy-protected healthcare data—designed to accelerate